Premium
Ustekinumab Fails to Show Efficacy in a Phase III Axial Spondyloarthritis Program: The Importance of Negative Results
Author(s) -
Mease Philip
Publication year - 2019
Publication title -
arthritis and rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.106
H-Index - 314
eISSN - 2326-5205
pISSN - 2326-5191
DOI - 10.1002/art.40759
Subject(s) - ustekinumab , phase (matter) , axial spondyloarthritis , medicine , computer science , physics , ankylosing spondylitis , disease , quantum mechanics , sacroiliitis , infliximab